Why the study?
Primary cardiac lymphoma is exceedingly uncommon with non-specific clinical presentations that complicate early diagnosis, creating a gap in clinical knowledge regarding its features, diagnostic evaluations, treatments, and prognosis.
Does chemotherapy or surgical intervention improve survival rates in patients with primary cardiac lymphoma?
Does chemotherapy or surgical intervention improve survival rates in patients with primary cardiac lymphoma?
In a review of 121 cases of primary cardiac lymphoma, chemotherapy was critical for improving survival, whereas surgery did not significantly affect survival rates.
Answers are grounded in this paper and cite their sources.
Chemotherapy warrants priority in primary cardiac lymphoma; leaves open surgery's role pending prospective validation.
Background: Primary cardiac lymphoma (PCL) is an exceedingly uncommon type of lymphoma that primarily affects the heart and/or pericardium, or manifests through cardiac symptoms due to myocardial infiltration. The infrequency of PCL, coupled with its non-specific clinical presentations, often complicates early diagnosis. This study aims to fill the existing gap in clinical knowledge regarding PCL by detailing a case of PCL and examining its clinical features, auxiliary examinations, treatment approaches, and prognostic outcomes, thereby facilitating early detection and enhancing patient care. Methods: A thorough search of the PubMed and Chinese National Knowledge Infrastructure (CNKI) database was performed using keywords "heart" and "lymphoma" or "primary cardiac lymphoma". This search encompassed publications from January 1, 2014, to November 1, 2024. Results: The review included 121 cases. These cases usually present with atypical symptoms, mainly circulatory and respiratory, including chest tightness, dyspnea, and edema, along with occasional neurological and gastrointestinal symptoms. Echocardiography served as the primary diagnostic method in 92.6% of cases, while a definitive diagnosis was achieved through pathological examination in all cases (100%). Treatment strategies predominantly included surgical intervention (44.6%) and chemotherapy (76.0%). Although surgery did not have a significant effect on survival rates, chemotherapy proved to be critical in improving patient survival. Conclusions: PCL, which arises in the cardiac or pericardial areas, is generally associated with a poor prognosis. It is essential for clinicians to develop a greater awareness and understanding of the characteristics of PCL to enhance early diagnosis. The timely initiation of chemotherapy is vital for improving survival rates and the overall quality of life for patients with PCL.
No takes yet. Share an insight, caveat, or question.
Chang et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: